Condition
Autoimmune Hepatitis clinical trials and research
As of November 12, 2026, Find a Trial lists 14 Autoimmune Hepatitis clinical trials that are recruiting, at sites in 11 countries (most in United States (6), Canada (3), China (2)). By phase: Phase 3 (1), Phase 2 (1), Phase 1 (1). The most active sponsors are Children's Hospital Medical Center, Cincinnati (3), University Health Network, Toronto (2). There are also 2 NIH-funded research projects on Autoimmune Hepatitis, with $592,500 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 2NIH research projects
- 11Countries
Newest Autoimmune Hepatitis clinical trials
All recruiting trials (14)
-
Inebilizumab for Autoimmune Hepatitis: a study in adults
This trial tests whether inebilizumab can be safely used in adults with autoimmune hepatitis and whether it helps reduce liver disease activity and the need for steroids.
-
Pediatric autoimmune hepatitis: can a vegan diet reduce reliance on immunosuppressants
In children with autoimmune hepatitis, this study tests whether adding a vegan diet for six months to standard treatment can help achieve liver disease remission compared with a standard high-protein diet.
-
Identifying liver disease-specific gut microbiomes
This study is trying to find out if certain gut bacteria are linked to chronic liver diseases in adults, including autoimmune hepatitis and primary biliary cholangitis, by analyzing blood and stool samples from patients and their household members.
-
Using Siplizumab to prevent immune issues in liver transplant patients with autoimmune liver disease
This study is testing if a new medication called siplizumab can help prevent immune problems in adults with autoimmune liver disease who are getting a liver transplant.
-
Using Belimumab to treat Autoimmune Hepatitis
This study is testing if Belimumab can help people with autoimmune hepatitis feel better and improve their liver function when other treatments haven't worked.
-
Comparing Mediterranean and Western diets for fatigue in autoimmune hepatitis patients
This study is testing whether following a Mediterranean diet or a Western diet can help reduce fatigue and improve quality of life for people with autoimmune hepatitis.
-
Creating a database for Autoimmune Hepatitis patients in Italy
This study is creating a database to collect important health information about Autoimmune Hepatitis patients in Italy to better understand how the disease affects them.
-
Predicting liver injury in autoimmune hepatitis using a specific antibody test
This study is testing if a specific antibody test can help doctors better diagnose autoimmune hepatitis in both adults and children, especially when other tests don't show clear results.
-
Observational study on autoimmune hepatitis in China
This study looks at the experiences and long-term health of people with autoimmune hepatitis in China to see how well different treatments work and what factors affect their recovery.
-
Improving outcomes in pediatric autoimmune liver disease
This study is trying to improve care for kids with autoimmune liver diseases by collecting and sharing information about their treatments and health to help doctors provide better support.
-
Nationwide registry for autoimmune liver diseases in Canada
This study is creating a detailed registry of people in Canada with autoimmune liver diseases like Primary Biliary Cholangitis and Autoimmune Hepatitis to better understand how these conditions progress over time.
-
Using MRI to predict outcomes in children with autoimmune liver disease
This study is testing if MRI scans can help predict how well children with autoimmune liver diseases will do over time.
-
Using MRI to assess liver damage in children with autoimmune liver disease
This study is testing if MRI scans can safely show liver damage in children with autoimmune liver diseases like PSC and AIH, helping doctors understand their condition better without needing invasive tests.
-
Swiss autoimmune hepatitis cohort
This project collects yearly health information and blood samples from people in Switzerland with autoimmune hepatitis to learn about the disease, treatments, and outcomes.
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Genetic clues to severe autoimmune hepatitis in adults
A study of people with severe autoimmune hepatitis to find genetic factors and protein markers that help explain why the disease is so serious.
-
Investigating how certain receptors affect immune responses in autoimmune hepatitis
This study is looking at how a specific part of the immune system affects autoimmune hepatitis, a liver disease, to find new ways to help improve treatment for people living with this condition.
Related topics
Quick answers
How many Autoimmune Hepatitis clinical trials are recruiting right now?
14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (6 trials), Canada (3 trials), China (2 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.